Robert J. Hombach

Insider · Director · EMBC

Robert J. Hombach files insider transactions with the SEC as a director of Embecta (EMBC). We hold 2 disclosed purchases and sales filed since 2 September 2010, 2 of them in the last 90 days.

Files forEMBC
Disclosed buys and sells2 in all, 2 in the last 90 days
Last disclosure13 August 2026

Positions held

8 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 1 April 2022 — 12 August 2026Director · Embecta (EMBC)7 Form 4 lines · source: SEC Form 4
Filed 30 April 2026 — 22 June 2026Director · Seaport Therapeutics (SPTX)2 Form 4 lines · source: SEC Form 4
Filed 29 September 2017 — 2 June 2026Director · Biomarin Pharmaceutical (BMRN)10 Form 4 lines · source: SEC Form 4
Filed 4 March 2025 — 6 March 2026Director · Henry Schein (HSIC)3 Form 4 lines · source: SEC Form 4
Filed 25 June 2018 — 26 May 2022Director · Aptinyx (APTX)21 Form 4 lines · source: SEC Form 4
Filed 29 June 2018 — 2 July 2021Director · Carmax (KMX)4 Form 4 lines · source: SEC Form 4
Filed 1 July 2015 — 3 June 2016EVP. CFO and COO · Baxalta (BXLT)25 Form 4 lines · source: SEC Form 4
Filed 1 September 2010 — 3 March 2015Corporate Vice President · Baxter International (BAX)35 Form 4 lines · source: SEC Form 4

Everything they disclosed

107 entries, newest first — one per disclosure report, one per Form 4 line

▲ bought on the open market 45,000 shares of EmbectaSEC Form 413 August 2026Common Stock · traded 12 August 2026 · filed 13 August 2026
▲ bought on the open market 13,000 shares of Seaport TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
was granted 7,490 shares of Biomarin PharmaceuticalSEC Form 44 June 2026Common Stock · traded 2 June 2026 · filed 4 June 2026
was granted 12,258 shares of Seaport Therapeutics (a derivative holding)SEC Form 44 May 2026Stock Option (Right to Buy) · traded 30 April 2026 · filed 4 May 2026
was granted 2,577 shares of Henry ScheinSEC Form 49 March 2026Common Stock par value $0.01 per share · traded 6 March 2026 · filed 9 March 2026
was granted 2,577 shares of Henry ScheinSEC Form 49 March 2026Common Stock par value $0.01 per share · traded 6 March 2026 · filed 9 March 2026
was granted 22,841 shares of EmbectaSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
was granted 22,841 shares of EmbectaSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
was granted 6,650 shares of Biomarin PharmaceuticalSEC Form 422 May 2025Common Stock · traded 20 May 2025 · filed 22 May 2025
was granted 2,844 shares of Henry ScheinSEC Form 46 March 2025Common Stock par value $0.01 per share · traded 4 March 2025 · filed 6 March 2025
was granted 13,839 shares of EmbectaSEC Form 414 February 2025Common Stock · traded 12 February 2025 · filed 14 February 2025
was granted 4,720 shares of Biomarin PharmaceuticalSEC Form 423 May 2024Common Stock · traded 21 May 2024 · filed 23 May 2024
was granted 11,455 shares of EmbectaSEC Form 49 February 2024Common Stock · traded 7 February 2024 · filed 9 February 2024
was granted 4,190 shares of Biomarin PharmaceuticalSEC Form 424 May 2023Common Stock · traded 23 May 2023 · filed 24 May 2023
was granted 6,979 shares of EmbectaSEC Form 410 February 2023Common Stock · traded 9 February 2023 · filed 10 February 2023
was granted 40,000 shares of Aptinyx (a derivative holding)SEC Form 431 May 2022Stock Option (Right to Buy) · traded 26 May 2022 · filed 31 May 2022
was granted 4,980 shares of Biomarin PharmaceuticalSEC Form 426 May 2022Common Stock · traded 24 May 2022 · filed 26 May 2022
was granted 6,024 shares of EmbectaSEC Form 45 April 2022Common Stock · traded 1 April 2022 · filed 5 April 2022
▲ bought on the open market 5,400 shares of AptinyxSEC Form 416 November 2021Common Stock · traded 11 November 2021 · filed 16 November 2021
▲ bought on the open market 74,600 shares of AptinyxSEC Form 416 November 2021Common Stock · traded 12 November 2021 · filed 16 November 2021
▲ bought on the open market 5,400 shares of AptinyxSEC Form 415 November 2021Common Stock · traded 11 November 2021 · filed 15 November 2021
▲ bought on the open market 74,600 shares of AptinyxSEC Form 415 November 2021Common Stock · traded 12 November 2021 · filed 15 November 2021
was granted 1,308 shares of CarmaxSEC Form 47 July 2021Common Stock · traded 2 July 2021 · filed 7 July 2021
was granted 40,000 shares of Aptinyx (a derivative holding)SEC Form 41 June 2021Stock Option (Right to Buy) · traded 27 May 2021 · filed 1 June 2021
was granted 5,120 shares of Biomarin PharmaceuticalSEC Form 427 May 2021Common Stock · traded 25 May 2021 · filed 27 May 2021
was granted 5,620 shares of Aptinyx (a derivative holding)SEC Form 45 January 2021Stock Option (Right to Buy) · traded 31 December 2020 · filed 5 January 2021
was granted 5,779 shares of Aptinyx (a derivative holding)SEC Form 42 October 2020Stock Option (Right to Buy) · traded 30 September 2020 · filed 2 October 2020
was granted 4,669 shares of Aptinyx (a derivative holding)SEC Form 42 July 2020Stock Option (Right to Buy) · traded 30 June 2020 · filed 2 July 2020
was granted 2,021 shares of CarmaxSEC Form 430 June 2020Common Stock · traded 26 June 2020 · filed 30 June 2020
was granted 4,300 shares of Biomarin PharmaceuticalSEC Form 429 May 2020Common Stock · traded 27 May 2020 · filed 29 May 2020
was granted 40,000 shares of Aptinyx (a derivative holding)SEC Form 422 May 2020Stock Option (Right to Buy) · traded 20 May 2020 · filed 22 May 2020
was granted 9,218 shares of Aptinyx (a derivative holding)SEC Form 42 April 2020Stock Option (Right to Buy) · traded 31 March 2020 · filed 2 April 2020
▲ bought on the open market 50,000 shares of AptinyxSEC Form 414 January 2020Common Stock · traded 10 January 2020 · filed 14 January 2020
was granted 5,835 shares of Aptinyx (a derivative holding)SEC Form 43 January 2020Stock Option (Right to Buy) · traded 31 December 2019 · filed 3 January 2020
▲ bought on the open market 50,000 shares of AptinyxSEC Form 426 November 2019Common Stock · traded 22 November 2019 · filed 26 November 2019
was granted 6,002 shares of Aptinyx (a derivative holding)SEC Form 42 October 2019Stock Option (Right to Buy) · traded 30 September 2019 · filed 2 October 2019
was granted 6,307 shares of Aptinyx (a derivative holding)SEC Form 42 July 2019Stock Option (Right to Buy) · traded 28 June 2019 · filed 2 July 2019
was granted 2,020 shares of CarmaxSEC Form 41 July 2019Common Stock · traded 28 June 2019 · filed 1 July 2019
was granted 4,430 shares of Biomarin PharmaceuticalSEC Form 46 June 2019Common Stock · traded 4 June 2019 · filed 6 June 2019
was granted 40,000 shares of Aptinyx (a derivative holding)SEC Form 417 May 2019Stock Option (Right to Buy) · traded 15 May 2019 · filed 17 May 2019
was granted 5,154 shares of Aptinyx (a derivative holding)SEC Form 42 April 2019Stock Option (Right to Buy) · traded 29 March 2019 · filed 2 April 2019
▲ bought on the open market 13,345 shares of AptinyxSEC Form 428 January 2019Common Stock · traded 24 January 2019 · filed 28 January 2019
▲ bought on the open market 11,655 shares of AptinyxSEC Form 428 January 2019Common Stock · traded 25 January 2019 · filed 28 January 2019
was granted 2,390 shares of CarmaxSEC Form 42 July 2018Common Stock · traded 29 June 2018 · filed 2 July 2018
▲ bought on the open market 24,100 shares of AptinyxSEC Form 426 June 2018Common Stock · traded 25 June 2018 · filed 26 June 2018
was granted 4,300 shares of Biomarin PharmaceuticalSEC Form 414 June 2018Common Stock · traded 5 June 2018 · filed 14 June 2018
was granted 3,180 shares of Biomarin PharmaceuticalSEC Form 43 October 2017Common Stock · traded 29 September 2017 · filed 3 October 2017
was granted 16,356 shares of BaxaltaSEC Form 47 June 2016Common Stock, par value $0.01 per share · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 209,089 shares of BaxaltaSEC Form 47 June 2016Common Stock, par value $0.01 per share · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 49,628 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 88,597 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 95,163 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 103,181 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 287,936 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 35,170 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 380,535 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
was granted 81,384 shares of BaxaltaSEC Form 47 March 2016Common Stock, par value $0.01 per share · traded 3 March 2016 · filed 7 March 2016
had shares withheld for tax on 5,900 shares of BaxaltaSEC Form 47 March 2016Common Stock, par value $0.01 per share · traded 3 March 2016 · filed 7 March 2016
was granted 4,070 shares of BaxaltaSEC Form 417 February 2016Common Stock, par value $0.01 per share · traded 15 February 2016 · filed 17 February 2016
had shares withheld for tax on 4,066 shares of BaxaltaSEC Form 417 February 2016Common Stock, par value $0.01 per share · traded 15 February 2016 · filed 17 February 2016
was granted 2,886 shares of BaxaltaSEC Form 417 February 2016Common Stock, par value $0.01 per share · traded 15 February 2016 · filed 17 February 2016
was granted 999 shares of BaxaltaSEC Form 413 August 2015Common Stock, par value $0.01 per share · traded 11 August 2015 · filed 13 August 2015
was granted 895 shares of BaxaltaSEC Form 413 August 2015Common Stock, par value $0.01 per share · traded 11 August 2015 · filed 13 August 2015
acquired or disposed of, other 22,568 shares of BaxaltaSEC Form 46 July 2015Common Stock, par value $0.01 per share · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 88,989 shares of BaxaltaSEC Form 46 July 2015Common Stock, par value $0.01 per share · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 49,628 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 88,597 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 95,163 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 103,181 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 287,936 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
was granted 380,535 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
was granted 35,170 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
was granted 17,536 shares of Baxter InternationalSEC Form 45 March 2015Common Stock, $1 par value · traded 3 March 2015 · filed 5 March 2015
was granted 132,890 shares of Baxter International (a derivative holding)SEC Form 45 March 2015Stock Option (Right to Buy) · traded 3 March 2015 · filed 5 March 2015
was granted 4,383 shares of Baxter InternationalSEC Form 418 February 2015Common Stock, $1 par value · traded 16 February 2015 · filed 18 February 2015
was granted 3,924 shares of Baxter InternationalSEC Form 418 February 2015Common Stock, $1 par value · traded 16 February 2015 · filed 18 February 2015
was granted 40,000 shares of Baxter InternationalSEC Form 44 June 2014Common Stock, $1 par value · traded 2 June 2014 · filed 4 June 2014
was granted 103,181 shares of Baxter International (a derivative holding)SEC Form 46 March 2014Stock Option (Right to Buy) · traded 4 March 2014 · filed 6 March 2014
was granted 3,015 shares of Baxter InternationalSEC Form 431 January 2014Common Stock, $1 par value · traded 29 January 2014 · filed 31 January 2014
had shares withheld for tax on 984 shares of Baxter InternationalSEC Form 431 January 2014Common Stock, $1 par value · traded 29 January 2014 · filed 31 January 2014
was granted 3,578 shares of Baxter InternationalSEC Form 431 January 2014Common Stock, $1 par value · traded 29 January 2014 · filed 31 January 2014
had shares withheld for tax on 2,530 shares of Baxter InternationalSEC Form 45 September 2013Common Stock, $1 par value · traded 3 September 2013 · filed 5 September 2013
exercised options over 5,040 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 1,240 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 6,200 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 2,424 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 6,064 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 1,587 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 5,290 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 1,200 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 6,000 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 12,407 shares of Baxter International (a derivative holding)SEC Form 424 July 2013Stock Option (Right to Buy) · traded 22 July 2013 · filed 24 July 2013
exercised options over 5,040 shares of Baxter InternationalSEC Form 424 July 2013Common Stock, $1 par value · traded 22 July 2013 · filed 24 July 2013
exercised options over 7,440 shares of Baxter InternationalSEC Form 424 July 2013Common Stock, $1 par value · traded 22 July 2013 · filed 24 July 2013
exercised options over 8,488 shares of Baxter InternationalSEC Form 424 July 2013Common Stock, $1 par value · traded 22 July 2013 · filed 24 July 2013
exercised options over 6,877 shares of Baxter InternationalSEC Form 424 July 2013Common Stock, $1 par value · traded 22 July 2013 · filed 24 July 2013
exercised options over 7,200 shares of Baxter InternationalSEC Form 424 July 2013Common Stock, $1 par value · traded 22 July 2013 · filed 24 July 2013
exercised options over 12,407 shares of Baxter InternationalSEC Form 424 July 2013Common Stock, $1 par value · traded 22 July 2013 · filed 24 July 2013
▼ sold on the open market 47,452 shares of Baxter InternationalSEC Form 424 July 2013Common Stock, $1 par value · traded 22 July 2013 · filed 24 July 2013
was granted 95,163 shares of Baxter International (a derivative holding)SEC Form 47 March 2013Stock Option (Right to Buy) · traded 5 March 2013 · filed 7 March 2013
was granted 1,673 shares of Baxter InternationalSEC Form 418 January 2013Common Stock, $1 par value · traded 16 January 2013 · filed 18 January 2013
had shares withheld for tax on 551 shares of Baxter InternationalSEC Form 418 January 2013Common Stock, $1 par value · traded 16 January 2013 · filed 18 January 2013
was granted 88,597 shares of Baxter International (a derivative holding)SEC Form 48 March 2012Stock Option (Right to Buy) · traded 6 March 2012 · filed 8 March 2012
was granted 74,442 shares of Baxter International (a derivative holding)SEC Form 48 March 2011Stock Options (Right to Buy) · traded 4 March 2011 · filed 8 March 2011
was granted 1,776 shares of Baxter InternationalSEC Form 421 January 2011Common Stock, $1 par value · traded 19 January 2011 · filed 21 January 2011
had shares withheld for tax on 618 shares of Baxter InternationalSEC Form 421 January 2011Common Stock, $1 par value · traded 19 January 2011 · filed 21 January 2011
was granted 5,000 shares of Baxter InternationalSEC Form 42 September 2010Common Stock, $1 par value · traded 1 September 2010 · filed 2 September 2010

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.